SEC Company Response from REGENTIS BIOMATERIALS LTD. (RGNT) (CIK 0001912966) (RGNT) — Sep 10, 2025
REGENTIS BIOMATERIALS LTD. (RGNT) (CIK 0001912966)
Date: Sept. 10, 2025 · CIK: 0001912966 · Accession: 0001213900-25-086460
AI Filing Summary & Sentiment
File numbers found in text: 333-285692
Letter
Regentis Biomaterials Ltd.
60 Medinat Hyahudim
Hertzliya, Israel 4676652
September 10, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE: Regentis Biomaterials Ltd. (CIK 0001912966)
Registration Statement No. 333-285692 on Form F-1 (the “Registration Statement”)
Ladies and Gentlemen:
Regentis Biomaterials Ltd. (the “Registrant”) hereby withdraws its request submitted on September 8, 2025 for acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), on September 10, 2025 at 5:00 p.m., Eastern Time.
Very truly yours,
REGENTIS BIOMATERIALS LTD.
Show Raw Text
CORRESP
1
filename1.htm
Regentis Biomaterials Ltd.
60 Medinat Hyahudim
Hertzliya, Israel 4676652
September 10, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE:
Regentis Biomaterials Ltd. (CIK 0001912966)
Registration Statement No. 333-285692 on Form F-1 (the “Registration Statement”)
Ladies and Gentlemen:
Regentis Biomaterials Ltd.
(the “Registrant”) hereby withdraws its request submitted on September 8, 2025 for acceleration of the effectiveness
of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities
Act”), on September 10, 2025 at 5:00 p.m., Eastern Time.
Very truly yours,
REGENTIS BIOMATERIALS LTD.
By:
/s/ Dr. Eli Hazum
Dr. Eli Hazum
Chief Executive Officer
cc: David Huberman (Greenberg Traurig, LLP)